Omega-3-Fettsäuren im Sport – Mängel erkennen und beheben

Clemens von Schacky

doi:10.1055/a-0761-1902

Zeitschrift für Orthomolekulare Medizin, Inhaltsverzeichnis

Zeitschrift für Orthomolekulare Medizin 2018; 16(04): 12-19
DOI: 10.1055/a-0761-1902

Wissen

Omega-3-Fettsäuren im Sport – Mängel erkennen und beheben

Clemens von Schacky

Abstract

Zusammenfassung

Bei Athleten, die ihren Körper in besonders starker Weise beanspruchen, erkennt man die vielfältigen Bedeutungen eines hohen ω-3-Indexes ebenso wie Leistungssportler in besonderer Weise von der Höhe ihres ω-3-Index abhängig sind. EPA und DHA, nicht die pflanzliche α-Linolensäure, sind geeignet, den ω-3-Index zu erhöhen. Ein ω-3-Index im Zielbereich von 8–11 % bedeutet Minimierung von Muskelkater und -abbau, eine Optimierung bestimmter kardiopulmonaler Parameter, eine Minimierung des Risikos für den plötzlichen Herztod, eine Optimierung komplexer kognitiver Leistungen wie Reaktionszeit oder Aufmerksamkeitsspanne, möglicherweise eine Minimierung der Konsequenzen von Hirntraumata, eine Optimierung der psychiatrischen/psychischen Situation und weitere positive Aspekte. Deshalb gehört die Bestimmung des HS-Omega-3-Index in die Laborroutine der Sportlerbetreuung. In den meisten Fällen wird ein ω-3-Index unterhalb des Zielbereiches von 8–11 % erkannt werden, was dann eine Supplementation mit entsprechenden Nahrungsergänzungsmitteln erfordert.

Schlüsselwörter

Omega-3-Fettsäuren - Muskel - Sport - Leistungssport - EPA - DHA - ω-3-Index - HS-Omega-3-Index - Supplementation

Volltext

Referenzen

Literatur
1 Plourde M, Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 2007; 32: 619-34
2 Kleber ME, Delgado GE, Lorkowski S, März W, von Schacky C. Omega-3 fatty acids and mortality in patients referred for coronary angiography – The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 2016; 252: 157-81
3 Witte AV, Kerti L, Hermannstädter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, Hahn A, Flöel A. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 2014; 24: 3059-68
4 Schuchardt JP, Hahn A. Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2013; 89: 1-8
5 Davidson MH, Johnson J, Rooney MW, Kyle ML, Kling DF. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova^®) compared to Lovaza^® in a pharmacokinetic single-dose evaluation study. J Clin Lipidol 2012; 6: 573-84
6 Köhler A, Bittner D, Löw A, von Schacky C. Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr 2010; 104: 729
7 Köhler A, Heinrich J, von Schacky C. Bioavailability of dietary omega-3 fatty acids in a variety of sausages in healthy individuals. Nutrients 2017; 9: 629
8 Hussey EK, Portelli S, Fossler MJ. et al. Relative bioavailability of an Emulsion Formulation for Omega-3-Acid Ethyl Esters Compared to the Commercially Available Formulation: A Randomized, Parallel-Group, Single-Dose Study Followed by Repeat dosing in healthy volunteers. Clin Pharm Drug Develop 2012; 1: 14-23
9 Qin Y, Nyheim H, Haram EM, Moritz JM, Hustvedt SO. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate. Lipids Health Dis 2017; 16: 204
10 Lane KE, Derbyshire EJ. Omega-3 fatty acids – A review of existing and innovative delivery methods. Crit Rev Food Sci Nutr 2018; 58: 62-69
11 Voruganti VS, Higgins PB, Ebbesson SOE. et al. Variants in CPT1A, FADS1, and FADS2 are associated with higher levels of estimated plasma and erythrocyte delta-5 desaturases in Alaskan Eskimos. Front Genet 2012; 3: 86
12 Harris WS, Pottala JV, Lacey SM, Vasan RS, Larson MG, Robins SJ. Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis 2012; 225: 425-31
13 Harris WS, and von Schacky C. The Omega-3 Index: A New Risk Factor for Death from CHD? Preventive Medicine. 2004; 39: 212-20
14 von Schacky C. Der HS-Omega 3 Index^®: klinische Wertigkeit standardisierter Fettsäureanalytik. J Lab Med 2014; 38: 167-78
15 von Schacky C. The Omega-3 Index as a Risk Factor for Cardiovascular Diseases. Prostaglandins and Other Lipid Mediators 2011; 96: 94-8
16 Heydari B, Abdullah S, Pottala JV. , et al. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial. Circulation 2016; 134: 378-91
17 Scorletti E, Bhatia L, McCormick KG. et al. WELCOME Study. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. Hepatology 2014; 60: 1211-21
18 von Schacky C. Omega-3 Index for Cardiovascular Health. Nutrients 2014; 6: 799-814
19 Hammond T, Gialloreto C, Kubas H, Hap Davis H. 4th. The prevalence of failure-based depression among elite athletes. Clin J Sport Med 2013; 23: 273-7
20 von Schacky C, Kemper M, Haslbauer R, Halle M. Low Omega-3 Index in 106 german elite winter endurance athletes: a pilot study. Int J Sport Nutr Exerc Metab 2014; 24: 559-64
21 Wilson PB, Madrigal LA. Associations Between Whole Blood and Dietary Omega-3 Polyunsaturated Fatty Acid Levels in Collegiate Athletes. Int J Sport Nutr Exerc Metab 2016; 26: 497-505
22 von Schacky C. Omega-3 Fettsäuren im Sport. Vitalstoffe 2015; 5/4: 10-16
23 Kim J, Lee J. A review of nutritional intervention on delayed onset muscle soreness. Part I J Exerc Rehabil 2014; 10: 349-56
24 Lembke P, Capodice J, Hebert K, Swenson T. Influence of omega-3 (n3) index on performance and wellbeing in young adults after heavy eccentric exercise. J Sports Sci Med 2014; 13: 151-6
25 Mickleborough TD, Sinex JA, Platt D, Chapman RF, Hirt M. The effects PCSO-524^®, a patented marine oil lipid and omega-3 PUFA blend derived from the New Zealand green lipped mussel (Perna canaliculus), on indirect markers of muscle damage and inflammation after muscle damaging exercise in untrained men: a randomized, placebo controlled trial. J Int Soc Sports Nutr 2015; 12: 10
26 Philpott JD, Donnelly C, Walshe IH. et al. Adding Fish Oil to Whey Protein, Leucine, and Carbohydrate Over a Six-Week Supplementation Period Attenuates Muscle Soreness Following Eccentric Exercise in Competitive Soccer Players. Int J Sport Nutr Exerc Metab 2018; 28: 26-36
27 Smith GI, Atherton P, Reeds DN. et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr 2011; 93: 402-12
28 Smith GI, Julliand S, Reeds DN, Sinacore DR, Klein S, Mittendorfer B. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr 2015; 102: 115-22
29 Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem N. Jr. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res 2016; 63: 132-52
30 Bloomer RJ, Larson DE, Fisher-Wellman KH, Galpin AJ, Schilling BK. Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammatory and oxidative stress biomarkers: a randomized, placebo controlled, cross-over study. Lipids Health Dis 2009; 8: 36
31 Tartibian B, Maleki BH, Abbasi A. Omega-3 fatty acids supplementation attenuates inflammatory markers after eccentric exercise in untrained men. Clin J Sport Med 2011; 21: 131-7
32 Walser B, Stebbins CL. Omega-3 fatty acid supplementation enhances stroke volume and cardiac output during dynamic exercise. Eur J Appl Physiol 2008; 104: 455-61
33 Peoples GE, McLennan PL, Howe PR, Groeller H. Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 2008; 52: 540-7
34 Buckley JD, Burgess S, Murphy KJ, Howe PR. DHA-rich fish oil lowers heart rate during submaximal exercise in elite Australian Rules footballers. J Sci Med Sport 2009; 12: 503-7
35 Macartney MJ, Hingley L, Brown MA, Peoples GE, McLennan PL. Intrinsic heart rate recovery after dynamic exercise is improved with an increased omega-3 index in healthy males. Br J Nutr 2014; 112: 1984-92
36 Moyers B, Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Relation of Whole Blood n-3 Fatty Acid Levels to Exercise Parameters in Patients With Stable Coronary Artery Disease (from the Heart and Soul Study). Am J Cardiol 2011; 107: 1149-54
37 AbuMweis S, Jew S, Tayyem R, Agraib L. Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials. J Human Nutr Diet 2018; 31: 67-81
38 Zebrowska A, Mizia-Stec K, Mizia M, Gąsior Z, Poprzęcki S. Omega-3 fatty acids supplementation improves endothelial function and maximal oxygen uptake in endurance-trained athletes. Eur J Sport Sci 2014 Sep 1: 1-10
39 Brilla LR, Landerholm TE. Effect of fish oil supplementation and exercise on serum lipids and aerobic fitness. J Sports Med Phys Fitness 1990; 30: 173-80
40 Raastad T, Høstmark AT, Strømme SB. Omega-3 fatty acid supplementation does not improve maximal aerobic power, anaerobic threshold and running performance in well-trained soccer players. Scand J Med Sci Sports 1997; 7: 25-31
41 https://www.wada-ama.org/sites/default/files/resources/files/2018_prohibited_list_german.pdf , aufgerufen am 12. 09.18
42 Harmon KG, Asif IM, Klossner D, Drezner JA. Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation 2011; 123: 1594-1600 . Clin J Sport Med 2013; 23: 273 – 7
43 Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol 2013; 61: 1027-40
44 Siscovick DS, Raghunathan TE, King I. et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the riskof primary cardiac arrest. J Am Med Assoc 1995; 275: 836-7
45 Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346: 1113-8
46 Marchioli R, Barzi F. Bomba et al. GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-903
47 Weiler JM, Brannan JD, Randolph CC. et al. Exercise-induced bronchoconstriction update-2016. J Allergy Clin Immunol 2016; 138: 1292-1295
48 Williams NC, Hunter KA, Shaw DE. et al. Comparable reductions in hyperpnoea-induced bronchoconstriction and markers of airway inflammation after supplementation with 6·2 and 3·1 g / d of long-chain n-3 PUFA in adults with asthma. Br J Nutr 2017; 117: 1379-89
49 Hart J Jr, Kraut MA, Womack KB, Strain J, Didehbani N, Bartz E, Conover H, Mansinghani S, Lu H, Cullum CM. Neuroimaging of cognitive dysfunction and depression in aging retired National Football League players: a cross-sectional study. JAMA Neurol 2013; 70: 326-35
50 Rubin TG, Catenaccio E, Fleysher R. et al. MRI-defined White Matter Microstructural Alteration Associated with Soccer Heading Is More Extensive in Women than Men. Radiology 2018; 289 (2): 478-86
51 Patricios JS, Ardern CL, Hislop MD. et al. Implementation of the 2017 Berlin Concussion in Sport Group Consensus Statement in contact and collision sports: a joint position statement from 11 national and international sports organisations. Br J Sports Med 2018; 52: 635-641
52 Oliver JM, Jones MT, Kirk KM. et al. Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football. Med Sci Sports Exerc 2016; 48: 974-82
53 Pu H, Jiang X, Wei Z. et al. Repetitive and Prolonged Omega-3 Fatty Acid Treatment After Traumatic Brain Injury Enhances Long-Term Tissue Restoration and Cognitive Recovery. Cell Transplant 2017; 26: 555-69
54 Noguchi H, Nishi D, Matsumura K, Hamazaki K, Hamazaki T, Matsuoka YJ. Limited effect of omega-3 fatty acids on the quality of life in survivors of traumatic injury: A randomized, placebo-controlled trial. Prostaglandins Leukot Essent Fatty Acids 2017; 127: 1-5
55 Guzmán JF, Esteve H, Pablos C, Pablos A, Blasco C, Villegas JA. DHA-Rich Fish Oil Improves Complex Reaction Time in Female Elite Soccer Players. J Sports Sci Med 2011; 10: 301-5
56 von Schacky C. ω-3 Fettsäuren und Hirnfunktion. Zs f Orthomol Med 2016; 2: 6-10
57 Grosso G, Pajak A, Marventano S. et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 2014; 9: e96905
58 Hibbeln JR, Gow RV. The potential for military diets to reduce depression, suicide, and impulsive aggression: a review of current evidence for omega-3 and omega-6 fatty acids. Mil Med 2014; 179 (11 Suppl): 117-28
59 von Schacky C. Omega-3 Fettsäuren und Major Depression. Vitalstoffe 2017; 3: 28-33
60 Ravindran AV, Balneaves LG, Faulkner G. et al. CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Can J Psychiatry 2016; 61: 576-87
61 McNamara RK, Welge JA. Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder. Bipolar Disord 2016; 18: 300-6
62 Saunders EF, Ramsden CE, Sherazy MS, Gelenberg AJ, Davis JM, Rapoport SI. Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Bipolar Disorder: A Review of Biomarker and Treatment Studies. J Clin Psychiatry 2016; 77: e1301-e1308
63 Naguy A. Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based? J Diet Suppl 2018; 15: 124-8
64 Messamore E, Almeida DM, Jandacek RJ, McNamara RK. Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application. Prog Lipid Res 2017; 66: 1-13
65 Messamore E, McNamara RK. Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation. Lipids Health Dis 2016; 15: 25
66 EFSA Journal. Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). 2012; 10 (07) : 2815
67 Yokoyama M, Origasa H, Matsuzaki M. et al. Japan EPA lipid intervention study (JELIS) Investigators. Japan EPA intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369: 1090-8